
Biography
Research Interests Bernard's research focusses on two themes, Pharmaceutical Regulation and Healthcare Management. More specifically he is interested in behaviours, technology, and regulation concerning the global health issue of substandard and falsified medicine. Regarding healthcare innovation, he is interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. His research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as Social Science and Medicine, BMJ Global Health and Lancet Global Health. He has also contributed to the regulatory affair's professional society, where he has authored several book chapters. Background Bernard is an Associate Professor and interdisciplinary researcher at the School of Pharmacy and Pharmaceutical Sciences at Trinity College Dublin where he is also the Director of the MSc in Pharmaceutical Manufacturing Technology. Prior to this appointment, Bernard was a research fellow at the Saïd Business School, and a member of St Antony's College, at the University of Oxford. Bernard holds a PhD in science and technology in medicine which was jointly supervised by the University of Oxford, Saïd Business School and the Institute of Science and Technology at Keele University. Bernard is a clinical pharmacist by training and has over ten years' experience working with large NHS teaching hospitals. Funders Bernards research has been funded by The University of Oxford, the Norwegian Research Council, the Wellcome Trust, and private technology firms. Other Engagements Bernard is an associate editor for the Sage journal The Journal of Medicine Access, and a Visiting Senior Lecturer in the Department of Cancer & Pharmaceutical Sciences, within the Faculty of Life Sciences & Medicine at King's College London. Bernard has also consulted for charities, education providers, professional and regulatory bodies, and the pharmaceutical industry.
Publications and Further Research Outputs
- Murphy N., Garvey E., Naughton B.D., Use of design thinking to develop a benchmarking tool to assess documentation procedures in a hospital pharmacy aseptic compounding unit: a case study, European Journal of Hospital Pharmacy, 2025Journal Article, 2025, DOI
- Naughton B.D., Planned Behavior in the United Kingdom and Ireland Online Medicine Purchasing Context: Mixed Methods Survey Study, JMIR Formative Research, 9, 2025Journal Article, 2025, DOI
- Naser K., Haq Z., Naughton B.D., The Impact of Climate Change on Health Services in Low- and Middle-Income Countries: A Systematised Review and Thematic Analysis, International Journal of Environmental Research and Public Health, 21, (4), 2024Review, 2024, DOI
Research Expertise
My research focusses on two themes, 1. Medicine Quality and 2. Healthcare Innovation. More specifically he is interested in estimating the problem as well as behaviour, technology, and regulation concerning substandard and falsified medicine. Regarding healthcare innovation, I am interested in the social processes of innovation, especially barriers to innovation, and responsible innovation. My research has implications for healthcare, governments, the pharmaceutical industry, major projects, and entrepreneurship. He uses both qualitative and quantitative research methods and has published in high impact journals such as BMJ Global Health and Lancet Global Health. I have also contributed to the regulatory affair's professional society, where I have authored several book chapters.
Recognition
- Royal Pharmaceutical Society of Great Britain Current
- Academy of Management Current
- Regulatory Affairs Professional Society Current